In recent years, you may have seen headlines like: Weight-loss or diabetes drug may reduce dementia risk. The drugs in question are GLP-1 receptor agonists (GLP-1 RAs) such as Semaglutide (Ozempic/Wegovy), Liraglutide (Victoza/Saxenda), and others
An a priori sample size calculation was performed using repeated measures, within factor ANOVA
Learn about the side effects, and potential benefits of DSIP peptide here
Nicole Martinez de Andino, a nurse practitioner and registered dietitian, directs clinical operations for the MUSC Weight Management Center
Individual results vary enormously based on injury severity, overall health, compliance with rehabilitation, and other factors
Host and microbiome genome-wide association studies: current state and challenges